Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-013762
Filing Date
2025-04-14
Accepted
2025-04-14 16:16:53
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-14

Document Format Files

Seq Description Document Type Size
1 ARS ef20047403_ars.pdf ARS 813383
  Complete submission text file 0001140361-25-013762.txt   1121633
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38981 | Film No.: 25836219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)